
About Salmed Laboratories Private Limited
Data last updated:
Salmed Laboratories Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33125GJ2005PTC046007. Its GSTIN is 24AAJCS5213M1Z7 (Gujarat).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Chintankumar Manubhai Patel and Himanshu Narendrakumar Patel.
Its last annual general meeting (AGM) was held on 01 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 13/14 Gopi Industrial Estate B/H Ramdev Masala Bavla Road Changodar, Ahmedabad, Gujarat, India – 382213.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.53 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹34.22 Lakh (net margin 6.2%) and EBITDA of ₹59.88 Lakh (EBITDA margin 10.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹1.51 Cr and satisfied charges of ₹48 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website salmedlab.in.
Company details
Contact details
Salmed Laboratories Private Limited's registered office is in Ahmedabad, Gujarat. Its website is salmedlab.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address13/14 Gopi Industrial Estate B/H Ramdev Masala Bavla Road Changodar, Ahmedabad, Gujarat, India – 382213
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Salmed Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Salmed Laboratories is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Salmed Laboratories Private Limited, buy the company report.
Financials of Salmed Laboratories Private Limited
FY 2025 filings availableSalmed Laboratories Private Limited reported revenue of ₹5.53 Cr (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 29% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹59.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.8% | ||||
| Net Profit Margin | 6.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Salmed Laboratories Private Limited, buy the company report.
Board of directors of Salmed Laboratories Private Limited
Salmed Laboratories has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chintankumar Manubhai Patel | Director | 06 May 2005 | 21 Years 6 Months | Current |
| Himanshu Narendrakumar Patel | Director | 21 Aug 2008 | 18 Years 2 Months | Current |
| Manubhai Fuljibhai Patel | Director | 21 Aug 2008 | 18 Years 2 Months | Current |
Auditor
Salmed Laboratories Private Limited is audited by J.M.PATEL & BROS. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J.M.PATEL & BROS. | FY 2023 | 107707W |
Shareholding
The shareholding of Salmed Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Salmed Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Aug 2025 | 101158861 | Saraspur Nagarik Co. Operative Bank Limited | ₹48 Lakh | Open | |
| 06 Jul 2024 | 100945048 | Hdfc Bank Limited | ₹18 Lakh | Open | |
| 09 May 2023 | 100732122 | Hdfc Bank Limited | ₹16.41 Lakh | Open | |
| 13 May 2009 | 10164417 | The Karur Vysya Bank Limited | ₹68.9 Lakh | Open | |
| 13 Jul 2022 | 100593113 | Saraspur Nagarik Co. Operative Bank Limited | ₹48 Lakh | Satisfied |
To see the full charge records of Salmed Laboratories Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Salmed Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Salmed Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Salmed Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCS5213M1Z7 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Salmed Laboratories Private Limited, buy the company report.
Recent activity
Salmed Laboratories Private Limited has 4 board changes on record since 2005: 3 appointments and 1 cessation. The latest: Tusharkumar Ambalal Patel ceased to be Director on 05 Dec 2008.
2 earlier events are in the company report.
Frequently asked questions
Salmed Laboratories is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 May 2005 (21+ years old) and is registered under CIN U33125GJ2005PTC046007.
Salmed Laboratories has 3 current directors:
- Chintankumar Manubhai Patel - Director
- Himanshu Narendrakumar Patel - Director
- Manubhai Fuljibhai Patel - Director
The latest financial statements of Salmed Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 01 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Salmed Laboratories is 24AAJCS5213M1Z7, registered in Gujarat.
The CIN (Corporate Identification Number) of Salmed Laboratories is U33125GJ2005PTC046007. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Salmed Laboratories was incorporated on 06 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Tusharkumar Ambalal Patel ceased to be Director on 05 Dec 2008. Himanshu Narendrakumar Patel was appointed as Director on 21 Aug 2008. Manubhai Fuljibhai Patel was appointed as Director on 21 Aug 2008. Salmed Laboratories has 4 board changes on record in total.
Salmed Laboratories can be reached through the website salmedlab.in. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Salmed Laboratories is at 1314 Gopi Industrial Estate BH Ramdev Masala Bavla Road Changodar, Ahmedabad, Gujarat, India – 382213.
Salmed Laboratories operates in the pharma industry, in the drug formulation and development segment.

